Inequalities in hormone replacement therapy prescribing in UK primary care: population based cohort study.

IF 10
BMJ medicine Pub Date : 2025-09-25 eCollection Date: 2025-01-01 DOI:10.1136/bmjmed-2025-001349
Jennifer A Hirst, Wema Meranda Mtika, Carol Coupland, Sharon Dixon, Julia Hippisley-Cox, Sarah Hillman
{"title":"Inequalities in hormone replacement therapy prescribing in UK primary care: population based cohort study.","authors":"Jennifer A Hirst, Wema Meranda Mtika, Carol Coupland, Sharon Dixon, Julia Hippisley-Cox, Sarah Hillman","doi":"10.1136/bmjmed-2025-001349","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To quantify prescribing of hormone replacement therapy (HRT) in women aged 40-60 years by type of HRT and length of use, and to determine sociodemographic factors associated with receiving a HRT prescription.</p><p><strong>Design: </strong>Population based cohort study.</p><p><strong>Setting: </strong>QResearch database of primary care practices in England, 1 January 2013 to 13 July 2023, and patient electronic health records for prescribing information .</p><p><strong>Participants: </strong>1 978 348 women aged 40-60 years at any time over a 10 year period.</p><p><strong>Main outcome measures: </strong>Overall uptake of two or more prescriptions of the same type of HRT in women of menopausal age, length of use, and association between ethnic group, deprivation, and geographical region and receiving a HRT prescription before and during the eight years since implementation of National Institute for Health and Care Excellence (NICE) guidance on the menopause in 2015 in the UK.</p><p><strong>Results: </strong>The cohort comprised 1 978 348 women with a mean age of 49.4 years, and 76.2% were white women. Overall, 379 911 (19.2%) women received two or more HRT prescriptions. Combination HRT formulations in one prescription were the most frequently prescribed (62.4% of those prescribed HRT), with 43.3% receiving oral and 26.3% transdermal formulations. Mean age at first prescription was 49.8 years. Rates for two or more prescriptions of HRT were higher in white women (22.6%) than in other ethnic groups, ranging from 8.9% in Caribbean women to 3.9% in black African women. Prescription rates decreased with increasing social deprivation, from 24.2% in the most affluent to 10.9% in the most deprived groups. London had lower prescription rates (11.7%) than other regions (all >19%). Multivariable Cox regression showed that non-white ethnic groups had significantly lower HRT prescription rates (hazard ratios 0.85-0.92, P<0.001), and each increase in social deprivation group was associated with lower HRT prescription rates (hazard ratio for the most deprived group 0.92, 95% confidence interval 0.92 to 0.93, P<0.001).</p><p><strong>Conclusions: </strong>This study identified differences in HRT prescribing in England based on ethnic group, socioeconomic status, and geographical location. White women and those in more affluent neighbourhoods were more likely to receive HRT than non-white women and those in more deprived areas. These findings suggest potential inequities that require further exploration.</p>","PeriodicalId":72433,"journal":{"name":"BMJ medicine","volume":"4 1","pages":"e001349"},"PeriodicalIF":10.0000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12481343/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjmed-2025-001349","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To quantify prescribing of hormone replacement therapy (HRT) in women aged 40-60 years by type of HRT and length of use, and to determine sociodemographic factors associated with receiving a HRT prescription.

Design: Population based cohort study.

Setting: QResearch database of primary care practices in England, 1 January 2013 to 13 July 2023, and patient electronic health records for prescribing information .

Participants: 1 978 348 women aged 40-60 years at any time over a 10 year period.

Main outcome measures: Overall uptake of two or more prescriptions of the same type of HRT in women of menopausal age, length of use, and association between ethnic group, deprivation, and geographical region and receiving a HRT prescription before and during the eight years since implementation of National Institute for Health and Care Excellence (NICE) guidance on the menopause in 2015 in the UK.

Results: The cohort comprised 1 978 348 women with a mean age of 49.4 years, and 76.2% were white women. Overall, 379 911 (19.2%) women received two or more HRT prescriptions. Combination HRT formulations in one prescription were the most frequently prescribed (62.4% of those prescribed HRT), with 43.3% receiving oral and 26.3% transdermal formulations. Mean age at first prescription was 49.8 years. Rates for two or more prescriptions of HRT were higher in white women (22.6%) than in other ethnic groups, ranging from 8.9% in Caribbean women to 3.9% in black African women. Prescription rates decreased with increasing social deprivation, from 24.2% in the most affluent to 10.9% in the most deprived groups. London had lower prescription rates (11.7%) than other regions (all >19%). Multivariable Cox regression showed that non-white ethnic groups had significantly lower HRT prescription rates (hazard ratios 0.85-0.92, P<0.001), and each increase in social deprivation group was associated with lower HRT prescription rates (hazard ratio for the most deprived group 0.92, 95% confidence interval 0.92 to 0.93, P<0.001).

Conclusions: This study identified differences in HRT prescribing in England based on ethnic group, socioeconomic status, and geographical location. White women and those in more affluent neighbourhoods were more likely to receive HRT than non-white women and those in more deprived areas. These findings suggest potential inequities that require further exploration.

英国初级保健中激素替代疗法处方的不平等:基于人群的队列研究。
目的:量化40-60岁女性激素替代疗法(HRT)的处方类型和使用时间,并确定与接受HRT处方相关的社会人口学因素。设计:基于人群的队列研究。设置:2013年1月1日至2023年7月13日英格兰初级保健实践的QResearch数据库,以及用于处方信息的患者电子健康记录。参与者:1978 348名年龄在40-60岁之间的女性,时间跨度为10年。主要结局指标:自2015年英国实施国家健康与护理卓越研究所(NICE)绝经指南以来的八年中,绝经年龄、使用时间、种族、剥夺和地理区域之间的关联以及接受HRT处方的两种或两种以上相同类型HRT处方的总体情况。结果:该队列包括1978 348名女性,平均年龄49.4岁,其中76.2%为白人女性。总体而言,379911名(19.2%)女性接受了两种或两种以上的激素替代疗法处方。联合HRT处方是最常见的处方(占处方HRT的62.4%),其中43.3%接受口服,26.3%接受透皮配方。首次处方的平均年龄为49.8岁。白人妇女服用两次或两次以上激素替代疗法的比率(22.6%)高于其他种族,从加勒比妇女的8.9%到非洲黑人妇女的3.9%不等。处方率随着社会剥夺程度的增加而下降,从最富裕人群的24.2%降至最贫困人群的10.9%。伦敦的处方率(11.7%)低于其他地区(所有地区均为19%)。多变量Cox回归分析显示,非白种人的HRT处方率显著低于白种人(风险比0.85-0.92,p)。结论:本研究确定了英国HRT处方在种族、社会经济地位和地理位置上的差异。白人妇女和生活在较富裕社区的妇女比非白人妇女和生活在较贫困地区的妇女更有可能接受激素替代疗法。这些发现表明,潜在的不平等需要进一步探索。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信